Supernus Pharmaceuticals, Inc(NASDAQ:SUPN) 
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. Its commercial products include Trokendi XR, an extended release topiramate product indicated for the t...
Website: http://www.supernus.com
Founded: 2005
Full Time Employees: 464
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenues | 147,000 | 91,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net product sales | 158,011,000 | 168,542,000 | 157,995,000 | 141,988,000 | 166,395,000 | 170,302,000 | 162,538,000 | 138,461,000 | 156,018,000 | 149,004,000 | 128,336,000 | 140,575,000 | 163,785,000 | 172,724,000 | 165,459,000 | 147,464,000 | 154,963,000 | 145,532,000 | 138,628,000 | 128,381,000 | 140,743,000 | 152,133,000 | 123,984,000 | 92,490,000 | 97,909,000 | 100,034,000 | 102,358,000 | 83,099,000 | 100,227,000 | 97,030,000 | 89,120,000 | 78,066,000 | 73,328,000 | 56,369,000 | 55,618,000 | 50,335,000 | 43,025,000 | 38,551,000 | 34,266,000 | 28,097,000 | 22,452,000 | 27,609,000 | 8,995,000 | 1,130,000 | 154,000 | ||||
collaboration revenue | 32,832,000 | 20,164,000 | |||||||||||||||||||||||||||||||||||||||||||||||
royalty, licensing and other revenues | 4,672,750 | 3,397,000 | 7,458,000 | 7,836,000 | 7,764,000 | 5,387,000 | 5,787,000 | ||||||||||||||||||||||||||||||||||||||||||
total revenues | 211,572,000 | 192,103,000 | 165,453,000 | 149,824,000 | 174,159,000 | 175,689,000 | 168,325,000 | 143,644,000 | 164,314,000 | 153,880,000 | 135,563,000 | 153,764,000 | 167,328,000 | 177,353,000 | 170,051,000 | 152,506,000 | 159,050,000 | 148,464,000 | 141,329,000 | 130,932,000 | 143,557,000 | 155,135,000 | 126,729,000 | 94,976,000 | 100,446,000 | 102,140,000 | 104,695,000 | 85,474,000 | 91,000 | 208,000 | |||||||||||||||||||
yoy | 21.48% | 9.34% | -1.71% | 4.30% | 5.99% | 14.17% | 24.17% | -6.58% | -1.80% | -13.24% | -20.28% | 0.82% | 5.20% | 19.46% | 20.32% | 16.48% | 10.79% | -4.30% | 11.52% | 37.86% | 42.92% | 51.88% | 21.05% | 11.12% | |||||||||||||||||||||||||
qoq | 10.13% | 16.11% | 10.43% | -13.97% | -0.87% | 4.37% | 17.18% | -12.58% | 6.78% | 13.51% | -11.84% | -8.11% | -5.65% | 4.29% | 11.50% | -4.11% | 7.13% | 5.05% | 7.94% | -8.79% | -7.46% | 22.41% | 33.43% | -5.45% | -1.66% | -2.44% | 22.49% | -56.25% | |||||||||||||||||||||
costs and expenses | |||||||||||||||||||||||||||||||||||||||||||||||||
cost of revenues | 23,007,000 | 18,965,000 | |||||||||||||||||||||||||||||||||||||||||||||||
research and development | 27,827,000 | 29,366,000 | 22,115,000 | 26,927,000 | 28,647,000 | 29,036,000 | 26,183,000 | 24,930,000 | 23,347,000 | 22,655,000 | 24,379,000 | 21,212,000 | 17,774,000 | 19,554,000 | 16,385,000 | 20,839,000 | 21,078,000 | 19,654,000 | 15,455,000 | 34,280,000 | 17,938,000 | 16,839,000 | 22,247,000 | 18,937,000 | 19,792,000 | 16,943,000 | 16,970,000 | 15,394,000 | 20,422,000 | 20,038,000 | 18,908,000 | 12,980,000 | 10,823,000 | 9,601,000 | 7,868,000 | 11,109,000 | 10,562,000 | 9,129,000 | 6,878,000 | 3,683,000 | 4,657,000 | 4,677,000 | 4,482,000 | 3,779,000 | 3,542,000 | 4,522,000 | 8,306,000 | 4,703,000 | 5,358,000 |
selling, general and administrative | 122,390,000 | 179,678,000 | 93,551,000 | 89,944,000 | 79,409,000 | 69,753,000 | 85,904,000 | 86,516,000 | 81,282,000 | 82,700,000 | 86,782,000 | 85,597,000 | 73,972,000 | 112,314,000 | 100,476,000 | 90,459,000 | 101,735,000 | 72,032,000 | 69,535,000 | 61,457,000 | 56,300,000 | 54,660,000 | 48,103,000 | 42,875,000 | 35,725,000 | 40,649,000 | 41,083,000 | 40,968,000 | 40,892,000 | 40,097,000 | 36,849,000 | 40,825,000 | 35,078,000 | 28,238,000 | 25,675,000 | 26,121,000 | 25,160,000 | 22,900,000 | 23,336,000 | 19,402,000 | 17,343,000 | 19,581,000 | 17,527,000 | 14,620,000 | 12,214,000 | 13,533,000 | 4,075,000 | 4,645,000 | |
amortization of intangible assets | 24,526,000 | 24,325,000 | 20,819,000 | 19,786,000 | 18,244,000 | 19,488,000 | 20,108,000 | 20,137,000 | 21,069,000 | 21,242,000 | 20,108,000 | 19,966,000 | 20,698,000 | 20,644,000 | 20,644,000 | 20,644,000 | 12,025,000 | 6,009,000 | 5,948,000 | 6,007,000 | 5,888,000 | 6,108,000 | 2,445,000 | ||||||||||||||||||||||||||
contingent consideration loss | 17,759,000 | 7,660,000 | |||||||||||||||||||||||||||||||||||||||||||||||
total costs and expenses | 215,509,000 | 252,334,000 | 153,312,000 | 160,080,000 | 152,754,000 | 134,844,000 | 145,756,000 | 146,797,000 | 165,310,000 | 145,742,000 | 153,150,000 | 148,588,000 | 132,994,000 | 178,876,000 | 158,705,000 | 150,539,000 | 152,952,000 | 115,860,000 | 107,216,000 | 117,718,000 | 100,559,000 | 98,995,000 | 81,181,000 | 65,964,000 | 59,630,000 | 62,411,000 | 62,097,000 | 60,046,000 | 65,521,000 | 63,818,000 | 59,035,000 | 58,056,000 | 49,762,000 | 40,788,000 | 36,971,000 | 39,981,000 | 37,757,000 | 34,277,000 | 31,976,000 | 24,703,000 | 23,321,000 | 25,919,000 | 22,503,000 | 18,432,000 | 15,760,000 | 18,055,000 | 12,381,000 | 9,348,000 | 8,086,000 |
operating earnings | -3,937,000 | -60,231,000 | 12,141,000 | 21,405,000 | 40,845,000 | 22,569,000 | -3,153,000 | -996,000 | 8,138,000 | -17,587,000 | 5,176,000 | 34,334,000 | -1,523,000 | 11,346,000 | 1,967,000 | 6,098,000 | 32,604,000 | 34,113,000 | 13,214,000 | 42,998,000 | 56,140,000 | 45,548,000 | 29,012,000 | 40,816,000 | 39,729,000 | 42,598,000 | 25,428,000 | 37,475,000 | 35,720,000 | 31,394,000 | |||||||||||||||||||
other income | 731,250 | -603,000 | 3,326,000 | 2,000 | 5,000 | 25,000 | 2,000 | 6,000 | 169,000 | 141,000 | |||||||||||||||||||||||||||||||||||||||
interest and other income | 2,023,000 | 2,277,000 | 4,528,000 | 4,425,000 | 4,977,000 | 4,098,000 | 3,733,000 | 3,396,000 | 1,986,000 | 1,751,000 | 1,370,000 | 5,346,000 | 2,400,000 | 2,803,000 | 1,788,000 | 14,698,000 | 1,887,000 | 2,281,000 | 2,589,000 | 3,812,000 | |||||||||||||||||||||||||||||
total other income | 2,023,000 | 2,277,000 | 4,528,000 | 4,425,000 | 4,977,000 | 4,098,000 | 3,733,000 | 3,396,000 | 1,986,000 | 1,751,000 | 460,000 | 3,841,000 | 806,000 | 1,079,000 | -22,000 | 12,756,000 | -2,878,000 | -2,285,000 | 1,662,000 | 22,000 | 568,000 | 358,000 | 292,000 | -11,878,000 | |||||||||||||||||||||||||
earnings before income taxes | -1,914,000 | -57,954,000 | 16,669,000 | -5,831,000 | 26,382,000 | 44,943,000 | 26,302,000 | 243,000 | 990,000 | 9,889,000 | -17,127,000 | 9,017,000 | 35,140,000 | -444,000 | 11,324,000 | 14,723,000 | 2,051,000 | 28,960,000 | 31,235,000 | 10,929,000 | 39,693,000 | 52,711,000 | 47,210,000 | 29,034,000 | 40,912,000 | 39,590,000 | 42,746,000 | 24,239,000 | 36,371,000 | 33,856,000 | 31,182,000 | 22,910,000 | 26,425,000 | 16,223,000 | 19,136,000 | 10,732,000 | 5,185,000 | 4,280,000 | 979,000 | ||||||||||
income tax expense | 2,191,000 | -12,837,000 | -5,830,000 | 5,996,000 | 11,054,000 | 6,446,000 | 6,386,000 | 119,000 | -185,000 | 25,865,000 | -16,296,000 | 9,659,000 | -2,193,000 | 3,459,000 | -10,893,000 | -391,000 | 7,398,000 | 7,509,000 | 5,235,000 | 8,925,000 | 12,714,000 | 12,543,000 | 7,516,000 | 7,783,000 | 10,730,000 | 10,019,000 | 5,899,000 | 8,360,000 | 3,119,000 | 4,830,000 | 6,949,000 | 9,057,000 | 5,926,000 | 714,000 | 198,000 | 58,000 | 662,000 | 62,000 | |||||||||||
net earnings | -4,105,000 | -45,117,000 | 22,499,000 | -11,827,000 | 15,328,000 | 38,497,000 | 19,916,000 | 124,000 | 1,175,000 | -15,976,000 | -831,000 | 16,948,000 | 25,481,000 | 1,749,000 | 7,865,000 | 25,616,000 | 2,442,000 | 21,562,000 | 23,726,000 | 5,694,000 | 30,768,000 | 39,997,000 | 34,667,000 | 21,518,000 | 33,129,000 | 28,860,000 | 32,727,000 | 18,340,000 | 28,011,000 | 30,737,000 | 26,352,000 | ||||||||||||||||||
yoy | -126.78% | -217.20% | 12.97% | -9637.90% | 1204.51% | -340.97% | -2496.63% | -99.27% | -95.39% | -1013.44% | -110.57% | -33.84% | 943.45% | -91.89% | -66.85% | 349.88% | -92.06% | -46.09% | -31.56% | -73.54% | -7.13% | 38.59% | 5.93% | 17.33% | 18.27% | -6.11% | 24.19% | ||||||||||||||||||||||
qoq | -90.90% | -300.53% | -290.23% | -177.16% | -60.18% | 93.30% | 15961.29% | -89.45% | -107.35% | 1822.50% | -104.90% | -33.49% | 1356.89% | -77.76% | -69.30% | 948.98% | -88.67% | -9.12% | 316.68% | -81.49% | -23.07% | 15.37% | 61.11% | -35.05% | 14.79% | -11.82% | 78.45% | -34.53% | -8.87% | 16.64% | |||||||||||||||||||
net income margin % | -1.94% | -23.49% | 13.60% | -7.89% | 8.80% | 21.91% | 11.83% | 0.09% | 0.72% | -10.38% | -0.61% | 11.02% | 15.23% | 0.99% | 4.63% | 16.80% | 1.54% | 14.52% | 16.79% | 4.35% | 21.43% | 25.78% | 27.36% | 22.66% | 32.98% | 28.26% | 31.26% | 21.46% | Infinity% | Infinity% | Infinity% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | 0% | 0% |
earnings per share | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.07 | -0.8 | 0.4 | -0.21 | 0.28 | 0.7 | 0.36 | -0.29 | -0.02 | 0.31 | 0.47 | 0.03 | 0.15 | 0.48 | 0.05 | 0.41 | 0.45 | 0.11 | 0.58 | 0.76 | 0.66 | 0.41 | 0.63 | 0.55 | 0.62 | 0.35 | 0.54 | 0.59 | 0.51 | 0.31 | 0.34 | 0.21 | |||||||||||||||||
diluted | -0.07 | -0.8 | 0.4 | -0.21 | 0.27 | 0.69 | 0.36 | -0.29 | -0.02 | 0.29 | 0.42 | 0.03 | 0.14 | 0.43 | 0.04 | 0.4 | 0.43 | 0.11 | 0.57 | 0.74 | 0.65 | 0.4 | 0.62 | 0.54 | 0.61 | 0.34 | 0.52 | 0.57 | 0.49 | 0.29 | 0.32 | 0.19 | |||||||||||||||||
weighted-average shares outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | 56,451,136 | 56,552,741 | 56,024,771 | 55,864,692 | 55,100,063 | 55,149,760 | 54,978,781 | 54,801,748 | 54,536,281 | 54,608,963 | 54,502,993 | 54,380,947 | 53,665,143 | 53,789,674 | 53,426,163 | 53,330,837 | 53,099,330 | 53,187,764 | 53,005,344 | 52,927,467 | 52,615,269 | 52,658,850 | 52,557,035 | 52,534,787 | 52,412,181 | 52,453,384 | 52,385,590 | 52,336,443 | 52,227,630 | 51,919,894 | 51,536,474 | 51,046,375 | 50,530,968 | 50,158,634 | 49,516,595,000 | 49,427,825,000 | 49,240,099,000 | 48,515,071,000 | 47,911,932,000 | 44,563,299,000 | 42,900,269,000 | 42,056,285,000 | 16,817,841,000 | 1,676,442,000 | |||||
diluted | 56,451,136 | 56,552,741 | 56,643,189 | 55,864,692 | 55,958,537 | 56,016,350 | 55,724,283 | 55,626,663 | 55,506,828 | 54,608,963 | 54,502,993 | 62,454,204 | 61,679,800 | 55,034,838 | 61,397,159 | 61,406,555 | 54,356,744 | 54,334,794 | 54,724,146 | 54,196,971 | 53,689,743 | 53,762,642 | 53,645,828 | 53,581,051 | 53,816,754 | 53,805,838 | 53,912,977 | 53,985,385 | 54,239,847 | 54,203,308 | 53,788,346 | 53,628,389 | 53,223,714 | 52,764,442 | 51,974,435,000 | 51,745,342,000 | 51,152,072,000 | 51,590,797,000 | 52,273,549,000 | 44,901,298,000 | 50,825,633,000 | 42,372,137,000 | 16,817,841,000 | 1,676,442,000 | |||||
cost of goods sold | 16,827,000 | 15,763,000 | 26,098,000 | 17,583,000 | 17,916,000 | 16,309,000 | 19,627,000 | 19,601,000 | 21,091,000 | 23,460,000 | 22,954,000 | 25,878,000 | 20,457,000 | 17,932,000 | 16,994,000 | 18,085,000 | 25,028,000 | 14,954,000 | 18,533,000 | 21,388,000 | 8,386,000 | 4,152,000 | 4,113,000 | 4,819,000 | |||||||||||||||||||||||||
operating income | -10,256,000 | 22,342,000 | 26,067,000 | 16,788,000 | 19,839,000 | 10,440,000 | 5,318,000 | 4,309,000 | 3,076,000 | 3,430,000 | 29,167,000 | 3,756,000 | -17,175,000 | -15,479,000 | |||||||||||||||||||||||||||||||||||
yoy | 114.00% | 390.17% | 289.60% | 544.96% | 204.37% | -81.77% | 14.72% | -119.97% | -288.43% | ||||||||||||||||||||||||||||||||||||||||
qoq | -14.29% | 55.27% | -15.38% | 90.03% | 96.31% | 23.42% | 40.08% | -10.32% | -88.24% | 676.54% | 10.96% | ||||||||||||||||||||||||||||||||||||||
operating margin % | 0% | 0% | 0% | -6.85% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | NaN% | NaN% | NaN% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | Infinity% | NaN% | -Infinity% | -Infinity% | NaN% | NaN% | 0% | 0% |
contingent consideration gain | 356,000 | -1,016,000 | -1,095,000 | -8,750,000 | |||||||||||||||||||||||||||||||||||||||||||||
interest expense | -910,000 | -1,505,000 | -1,594,000 | -1,724,000 | -1,810,000 | -1,942,000 | -5,934,000 | -5,925,000 | -5,467,000 | -6,097,000 | -6,096,000 | -6,088,000 | -5,815,000 | -5,755,000 | -2,870,000 | -2,144,000 | |||||||||||||||||||||||||||||||||
contingent consideration expense | -4,355,000 | -328,250 | -456,000 | 790,000 | 473,500 | 486,000 | 743,000 | 665,000 | -1,912,500 | 80,000 | 1,020,000 | ||||||||||||||||||||||||||||||||||||||
royalty and licensing revenues | 5,183,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
royalty revenues | 6,323,000 | 4,876,000 | 7,227,000 | 13,189,000 | 3,543,000 | 4,629,000 | 4,592,000 | 5,042,000 | 2,046,000 | 2,932,000 | 2,701,000 | 2,551,000 | 2,058,250 | 3,002,000 | 2,745,000 | 2,486,000 | 1,704,500 | 2,106,000 | 2,337,000 | 2,375,000 | |||||||||||||||||||||||||||||
contingent consideration (gain) expense | -1,647,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | -7,931,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
total other expense | -4,047,000 | -3,644,000 | -3,305,000 | -3,429,000 | -6,921,000 | ||||||||||||||||||||||||||||||||||||||||||||
interest income | 3,247,000 | 3,262,000 | 4,151,000 | 5,777,000 | 4,461,000 | 3,664,000 | 1,206,000 | 814,000 | 656,000 | 531,000 | 379,000 | 363,000 | 331,000 | 169,000 | 137,000 | 113,000 | 78,000 | 85,000 | 102,000 | 96,000 | 55,000 | 52,000 | 39,000 | 32,000 | 19,000 | ||||||||||||||||||||||||
licensing revenues | |||||||||||||||||||||||||||||||||||||||||||||||||
other income (expenses) | -295,000 | -139,000 | 148,000 | ||||||||||||||||||||||||||||||||||||||||||||||
cost of product sales | 4,044,000 | 3,684,000 | 4,207,000 | 3,683,000 | 3,278,000 | 4,251,000 | 3,861,000 | 2,949,000 | 3,428,000 | 2,751,000 | 2,035,000 | 2,248,000 | 1,762,000 | 1,618,000 | 1,321,000 | 1,661,000 | 494,000 | 33,000 | 4,000 | ||||||||||||||||||||||||||||||
other expenses | |||||||||||||||||||||||||||||||||||||||||||||||||
revenue | |||||||||||||||||||||||||||||||||||||||||||||||||
royalty revenue | 2,769,000 | 1,758,000 | 1,309,000 | 2,010,000 | 1,179,000 | 1,149,000 | 1,140,000 | ||||||||||||||||||||||||||||||||||||||||||
licensing revenue | 750,000 | 322,000 | 1,322,000 | 58,000 | 52,000 | 86,000 | 50,000 | 35,000 | 786,000 | 36,000 | 36,000 | 2,066,000 | 86,000 | 127,000 | 127,000 | ||||||||||||||||||||||||||||||||||
total revenue | 102,996,000 | 99,538,000 | 90,429,000 | 80,398,000 | 75,829,000 | 57,576,000 | 56,810,000 | 50,421,000 | 43,075,000 | 38,586,000 | 35,052,000 | 28,133,000 | 52,488,000 | 29,675,000 | 9,081,000 | 1,257,000 | 281,000 | ||||||||||||||||||||||||||||||||
interest expense-nonrecourse liability related to sale of future royalties | |||||||||||||||||||||||||||||||||||||||||||||||||
changes in fair value of derivative liabilities | 23,000 | 54,000 | 125,000 | 123,000 | 101,000 | 114,000 | 1,000 | 760,000 | 678,000 | 677,000 | -4,153,000 | -8,619,000 | |||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | -1,162,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | -0.07 | -0.8 | 0.4 | -0.21 | 0.28 | 0.7 | 0.36 | -0.29 | -0.02 | 0.31 | 0.47 | 0.03 | 0.15 | 0.48 | 0.05 | 0.41 | 0.45 | 0.11 | 0.58 | 0.76 | 0.66 | 0.41 | 0.63 | 0.55 | 0.62 | 0.35 | 0.54 | 0.59 | 0.51 | 0.31 | 0.34 | 0.21 | |||||||||||||||||
diluted | -0.07 | -0.8 | 0.4 | -0.21 | 0.27 | 0.69 | 0.36 | -0.29 | -0.02 | 0.29 | 0.42 | 0.03 | 0.14 | 0.43 | 0.04 | 0.4 | 0.43 | 0.11 | 0.57 | 0.74 | 0.65 | 0.4 | 0.62 | 0.54 | 0.61 | 0.34 | 0.52 | 0.57 | 0.49 | 0.29 | 0.32 | 0.19 | |||||||||||||||||
weighted-average number of common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | 56,451,136 | 56,552,741 | 56,024,771 | 55,864,692 | 55,100,063 | 55,149,760 | 54,978,781 | 54,801,748 | 54,536,281 | 54,608,963 | 54,502,993 | 54,380,947 | 53,665,143 | 53,789,674 | 53,426,163 | 53,330,837 | 53,099,330 | 53,187,764 | 53,005,344 | 52,927,467 | 52,615,269 | 52,658,850 | 52,557,035 | 52,534,787 | 52,412,181 | 52,453,384 | 52,385,590 | 52,336,443 | 52,227,630 | 51,919,894 | 51,536,474 | 51,046,375 | 50,530,968 | 50,158,634 | 49,516,595,000 | 49,427,825,000 | 49,240,099,000 | 48,515,071,000 | 47,911,932,000 | 44,563,299,000 | 42,900,269,000 | 42,056,285,000 | 16,817,841,000 | 1,676,442,000 | |||||
diluted | 56,451,136 | 56,552,741 | 56,643,189 | 55,864,692 | 55,958,537 | 56,016,350 | 55,724,283 | 55,626,663 | 55,506,828 | 54,608,963 | 54,502,993 | 62,454,204 | 61,679,800 | 55,034,838 | 61,397,159 | 61,406,555 | 54,356,744 | 54,334,794 | 54,724,146 | 54,196,971 | 53,689,743 | 53,762,642 | 53,645,828 | 53,581,051 | 53,816,754 | 53,805,838 | 53,912,977 | 53,985,385 | 54,239,847 | 54,203,308 | 53,788,346 | 53,628,389 | 53,223,714 | 52,764,442 | 51,974,435,000 | 51,745,342,000 | 51,152,072,000 | 51,590,797,000 | 52,273,549,000 | 44,901,298,000 | 50,825,633,000 | 42,372,137,000 | 16,817,841,000 | 1,676,442,000 | |||||
weighted-average number of common shares outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | 56,451,136 | 56,552,741 | 56,024,771 | 55,864,692 | 55,100,063 | 55,149,760 | 54,978,781 | 54,801,748 | 54,536,281 | 54,608,963 | 54,502,993 | 54,380,947 | 53,665,143 | 53,789,674 | 53,426,163 | 53,330,837 | 53,099,330 | 53,187,764 | 53,005,344 | 52,927,467 | 52,615,269 | 52,658,850 | 52,557,035 | 52,534,787 | 52,412,181 | 52,453,384 | 52,385,590 | 52,336,443 | 52,227,630 | 51,919,894 | 51,536,474 | 51,046,375 | 50,530,968 | 50,158,634 | 49,516,595,000 | 49,427,825,000 | 49,240,099,000 | 48,515,071,000 | 47,911,932,000 | 44,563,299,000 | 42,900,269,000 | 42,056,285,000 | 16,817,841,000 | 1,676,442,000 | |||||
diluted | 56,451,136 | 56,552,741 | 56,643,189 | 55,864,692 | 55,958,537 | 56,016,350 | 55,724,283 | 55,626,663 | 55,506,828 | 54,608,963 | 54,502,993 | 62,454,204 | 61,679,800 | 55,034,838 | 61,397,159 | 61,406,555 | 54,356,744 | 54,334,794 | 54,724,146 | 54,196,971 | 53,689,743 | 53,762,642 | 53,645,828 | 53,581,051 | 53,816,754 | 53,805,838 | 53,912,977 | 53,985,385 | 54,239,847 | 54,203,308 | 53,788,346 | 53,628,389 | 53,223,714 | 52,764,442 | 51,974,435,000 | 51,745,342,000 | 51,152,072,000 | 51,590,797,000 | 52,273,549,000 | 44,901,298,000 | 50,825,633,000 | 42,372,137,000 | 16,817,841,000 | 1,676,442,000 | |||||
net income | 15,961,000 | 17,368,000 | 10,297,000 | 61,826,000 | 10,018,000 | 4,987,000 | 4,222,000 | 2,005,000 | 917,000 | 27,858,000 | 3,202,000 | -15,543,000 | -24,096,000 | -27,357,000 | -13,482,000 | -9,277,000 | |||||||||||||||||||||||||||||||||
interest expense-non-recourse royalty liability | |||||||||||||||||||||||||||||||||||||||||||||||||
income per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | 1,250 | 200 | 100 | 90 | 20 | 650 | 80 | ||||||||||||||||||||||||||||||||||||||||||
diluted | 1,180 | 180 | 80 | 80 | 20 | 390 | 80 | ||||||||||||||||||||||||||||||||||||||||||
other expense | |||||||||||||||||||||||||||||||||||||||||||||||||
revenue from royalty agreement | 30,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
earnings (loss) before income taxes | 2,667,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
income (loss) per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | 40 | ||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 30 | ||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common shares: | |||||||||||||||||||||||||||||||||||||||||||||||||
basic | 56,451,136 | 56,552,741 | 56,024,771 | 55,864,692 | 55,100,063 | 55,149,760 | 54,978,781 | 54,801,748 | 54,536,281 | 54,608,963 | 54,502,993 | 54,380,947 | 53,665,143 | 53,789,674 | 53,426,163 | 53,330,837 | 53,099,330 | 53,187,764 | 53,005,344 | 52,927,467 | 52,615,269 | 52,658,850 | 52,557,035 | 52,534,787 | 52,412,181 | 52,453,384 | 52,385,590 | 52,336,443 | 52,227,630 | 51,919,894 | 51,536,474 | 51,046,375 | 50,530,968 | 50,158,634 | 49,516,595,000 | 49,427,825,000 | 49,240,099,000 | 48,515,071,000 | 47,911,932,000 | 44,563,299,000 | 42,900,269,000 | 42,056,285,000 | 16,817,841,000 | 1,676,442,000 | |||||
diluted | 56,451,136 | 56,552,741 | 56,643,189 | 55,864,692 | 55,958,537 | 56,016,350 | 55,724,283 | 55,626,663 | 55,506,828 | 54,608,963 | 54,502,993 | 62,454,204 | 61,679,800 | 55,034,838 | 61,397,159 | 61,406,555 | 54,356,744 | 54,334,794 | 54,724,146 | 54,196,971 | 53,689,743 | 53,762,642 | 53,645,828 | 53,581,051 | 53,816,754 | 53,805,838 | 53,912,977 | 53,985,385 | 54,239,847 | 54,203,308 | 53,788,346 | 53,628,389 | 53,223,714 | 52,764,442 | 51,974,435,000 | 51,745,342,000 | 51,152,072,000 | 51,590,797,000 | 52,273,549,000 | 44,901,298,000 | 50,825,633,000 | 42,372,137,000 | 16,817,841,000 | 1,676,442,000 | |||||
loss per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | -380 | -780 | -890 | -600 | |||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common shares: | |||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted | 41,129,055,000 | 30,941,404,000 | 30,897,075,000 | 30,875,424,000 | 24,464,281,000 | ||||||||||||||||||||||||||||||||||||||||||||
cumulative dividends on series a | |||||||||||||||||||||||||||||||||||||||||||||||||
convertible preferred stock | |||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to common stockholders | -24,096,000 | -27,357,000 | -18,414,000 | -13,482,000 | -10,135,000 | ||||||||||||||||||||||||||||||||||||||||||||
cumulative dividends on series a convertible preferred stock | -858,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
other income: | |||||||||||||||||||||||||||||||||||||||||||||||||
operating loss from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
loss from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations: | |||||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
continuing operations | -550 | -6,050 | |||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
development and milestone revenues | 91,000 | 208,000 | |||||||||||||||||||||||||||||||||||||||||||||||
general and administrative | 2,728,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
other | |||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 184,869,000 | 128,448,000 | 151,371,000 | 144,711,000 | 115,848,000 | 69,331,000 | 31,673,000 | 52,089,000 | 63,401,000 | 75,054,000 | 94,985,000 | 24,706,000 | 58,442,000 | 93,120,000 | 111,492,000 | 173,428,000 | 115,715,000 | 203,434,000 | 215,281,000 | 223,771,000 | 255,642,000 | 288,640,000 | 204,293,000 | 210,975,000 | 225,767,000 | 181,381,000 | 116,889,000 | 87,344,000 | 122,778,000 | 123,818,000 | 35,205,000 | 444,140,000 | 81,924,000 | 61,737,000 | 59,599,000 | 54,305,000 | 36,156,000 | 19,830,000 | 26,294,000 | 33,110,000 | 25,810,000 | 37,780,000 | 11,956,000 | 12,252,000 | 22,945,000 | 33,907,000 | 18,909,000 | 23,412,000 | 47,242,000 | 15,866,000 |
marketable securities | 199,372,000 | 180,222,000 | 129,789,000 | 377,885,000 | 347,742,000 | 384,281,000 | 371,537,000 | 295,098,000 | 234,335,000 | 179,820,000 | 105,204,000 | 126,950,000 | 170,126,000 | 368,214,000 | 280,297,000 | 187,359,000 | 196,485,000 | 136,246,000 | 228,571,000 | 186,070,000 | 135,459,000 | 133,893,000 | 147,657,000 | 163,839,000 | 175,104,000 | 165,692,000 | 179,808,000 | 171,222,000 | 170,165,000 | 156,407,000 | 139,208,000 | 45,585,000 | 32,626,000 | 31,229,000 | 27,533,000 | 26,024,000 | 24,058,000 | 25,427,000 | 31,408,000 | 36,681,000 | 39,026,000 | 34,783,000 | 35,314,000 | 46,615,000 | 64,293,000 | 68,725,000 | 50,983,000 | 37,256,000 | 29,150,000 | 21,513,000 |
accounts receivable | 182,183,000 | 187,802,000 | 171,254,000 | 140,831,000 | 145,640,000 | 142,077,000 | 145,408,000 | 152,494,000 | 147,734,000 | 144,155,000 | 141,764,000 | 136,556,000 | 143,568,000 | 165,497,000 | 164,086,000 | 158,063,000 | 145,149,000 | 148,932,000 | 133,676,000 | 137,275,000 | 127,065,000 | 140,877,000 | 133,107,000 | 126,559,000 | 119,195,000 | 87,332,000 | 86,699,000 | 84,564,000 | 79,950,000 | 77,753,000 | 74,842,000 | 67,864,000 | 56,166,000 | 51,157,000 | 38,885,000 | 36,220,000 | 34,281,000 | 30,651,000 | 23,603,000 | 17,900,000 | 19,271,000 | 15,303,000 | 10,854,000 | 9,725,000 | 7,208,000 | 537,000 | 1,650,000 | 500,000 | ||
inventories | 87,062,000 | 82,385,000 | 79,399,000 | 44,023,000 | 49,423,000 | 54,293,000 | 63,981,000 | 68,155,000 | 75,079,000 | 77,408,000 | 83,480,000 | 90,560,000 | 91,147,000 | 91,541,000 | 83,165,000 | 84,860,000 | 88,795,000 | 85,959,000 | 60,155,000 | 58,391,000 | 50,226,000 | 48,325,000 | 42,465,000 | 35,338,000 | 24,418,000 | 26,628,000 | 25,504,000 | 26,024,000 | 26,518,000 | 23,280,000 | 20,680,000 | 19,075,000 | 14,947,000 | 16,623,000 | 19,167,000 | 17,453,000 | 16,373,000 | 13,044,000 | 14,742,000 | 13,592,000 | 13,702,000 | 11,145,000 | 10,101,000 | 7,957,000 | 5,188,000 | 4,315,000 | 3,113,000 | |||
prepaid expenses and other current assets | 78,094,000 | 65,325,000 | 62,078,000 | 31,416,000 | 28,931,000 | 36,088,000 | 27,404,000 | 23,166,000 | 23,772,000 | 16,676,000 | 23,927,000 | 44,766,000 | 16,299,000 | 15,779,000 | 24,846,000 | 21,410,000 | 22,372,000 | 27,019,000 | 30,692,000 | 33,737,000 | 17,631,000 | 18,682,000 | 24,493,000 | 20,442,000 | 12,564,000 | 11,611,000 | 18,182,000 | 21,757,000 | 20,556,000 | 9,299,000 | 14,581,000 | 6,582,000 | 5,667,000 | 4,746,000 | 4,573,000 | 4,201,000 | 3,272,000 | 5,003,000 | 6,504,000 | 4,457,000 | 3,696,000 | 3,298,000 | 3,058,000 | 2,559,000 | ||||||
total current assets | 731,580,000 | 644,182,000 | 593,891,000 | 738,866,000 | 687,584,000 | 686,070,000 | 640,003,000 | 591,002,000 | 544,321,000 | 493,113,000 | 449,360,000 | 423,538,000 | 883,340,000 | 734,151,000 | 663,886,000 | 625,120,000 | 568,516,000 | 601,590,000 | 668,375,000 | 639,244,000 | 586,023,000 | 630,417,000 | 552,015,000 | 557,153,000 | 557,048,000 | 472,644,000 | 427,082,000 | 390,911,000 | 419,967,000 | 390,557,000 | 284,516,000 | 583,246,000 | 191,330,000 | 165,492,000 | 149,757,000 | 138,203,000 | 114,140,000 | 93,955,000 | 102,551,000 | 105,740,000 | 101,505,000 | 102,968,000 | 71,981,000 | 79,929,000 | 102,862,000 | 110,617,000 | 76,332,000 | 62,889,000 | 77,805,000 | 38,417,000 |
restricted cash | 1,450,000 | 1,450,000 | 1,450,000 | 403,758,000 | ||||||||||||||||||||||||||||||||||||||||||||||
property and equipment | 10,042,000 | 10,531,000 | 10,627,000 | 11,069,000 | 11,338,000 | 11,545,000 | 11,876,000 | 12,274,000 | 12,969,000 | 13,530,000 | 13,688,000 | 14,186,000 | 14,611,000 | 15,173,000 | 15,872,000 | 16,317,000 | 17,215,000 | 16,955,000 | 16,471,000 | 17,065,000 | 37,950,000 | 37,824,000 | 17,395,000 | 17,941,000 | 18,011,000 | 17,068,000 | 9,977,000 | 4,028,000 | 4,226,000 | 6,930,000 | 4,897,000 | 5,003,000 | 4,688,000 | 4,572,000 | 4,342,000 | 4,318,000 | 4,193,000 | 3,866,000 | 3,210,000 | 2,908,000 | 2,481,000 | 2,500,000 | 2,590,000 | 2,648,000 | 2,480,000 | 2,247,000 | 1,687,000 | 1,384,000 | 1,146,000 | 1,183,000 |
intangible assets | 549,712,000 | 569,456,000 | 623,481,000 | 481,307,000 | 502,126,000 | 521,912,000 | 540,156,000 | 559,644,000 | 579,752,000 | 599,889,000 | 641,147,000 | 662,389,000 | 682,497,000 | 702,463,000 | 722,761,000 | 743,405,000 | 764,049,000 | 784,693,000 | 346,619,000 | 352,628,000 | 358,736,000 | 364,342,000 | 402,265,000 | 408,272,000 | 23,579,000 | 24,840,000 | 26,101,000 | 28,787,000 | 30,063,000 | 32,572,000 | 33,794,000 | 34,858,000 | 37,162,000 | 28,989,000 | 29,450,000 | 15,526,000 | 15,785,000 | 16,108,000 | 16,627,000 | 11,597,000 | 7,839,000 | 4,135,000 | 3,083,000 | 2,157,000 | 817,000 | |||||
goodwill | 120,668,000 | 124,882,000 | 119,080,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,019,000 | 117,383,000 | 115,414,000 | 115,414,000 | 117,516,000 | 77,963,000 | 77,963,000 | 77,911,000 | 77,911,000 | 89,143,000 | 88,095,000 | ||||||||||||||||||||||||||
deferred income tax assets | 30,820,000 | 38,351,000 | 8,793,000 | 6,181,000 | ||||||||||||||||||||||||||||||||||||||||||||||
other assets | 56,453,000 | 63,796,000 | 62,432,000 | 27,963,000 | 29,223,000 | 31,527,000 | 33,647,000 | 35,890,000 | 38,367,000 | 37,505,000 | 38,821,000 | 38,489,000 | 40,184,000 | 39,806,000 | 41,290,000 | 47,344,000 | 48,986,000 | 49,232,000 | 40,133,000 | 40,687,000 | 30,257,000 | 43,249,000 | 18,324,000 | 17,118,000 | 538,000 | 615,000 | 574,000 | 581,000 | 625,000 | 360,000 | 360,000 | 363,000 | 55,000 | 55,000 | 61,000 | |||||||||||||||
total assets | 1,500,725,000 | 1,452,648,000 | 1,419,754,000 | 1,382,405,000 | 1,347,290,000 | 1,368,073,000 | 1,342,701,000 | 1,315,829,000 | 1,304,090,000 | 1,277,673,000 | 1,285,160,000 | 1,293,099,000 | 1,791,808,000 | 1,702,508,000 | 1,693,129,000 | 1,694,973,000 | 1,639,517,000 | 1,689,152,000 | 1,555,040,000 | 1,573,060,000 | 1,507,443,000 | 1,504,102,000 | 1,510,022,000 | 1,491,020,000 | 1,189,866,000 | 1,160,282,000 | 1,106,909,000 | 1,063,675,000 | 1,025,448,000 | 922,512,000 | 852,799,000 | 825,160,000 | 385,478,000 | 346,370,000 | 322,256,000 | 285,116,000 | 218,633,000 | 194,474,000 | 166,770,000 | 154,168,000 | 139,637,000 | 126,325,000 | 94,190,000 | 97,520,000 | 123,765,000 | 131,973,000 | 79,061,000 | 67,014,000 | 79,965,000 | 43,202,000 |
liabilities and stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable and accrued liabilities | 101,244,000 | 107,800,000 | 108,613,000 | 77,739,000 | 76,891,000 | 76,352,000 | 75,803,000 | 82,611,000 | 86,402,000 | 79,569,000 | 78,471,000 | 83,044,000 | 95,345,000 | 96,342,000 | 110,302,000 | 133,000,000 | 89,432,000 | 117,683,000 | 72,286,000 | 79,993,000 | 70,099,000 | 78,934,000 | ||||||||||||||||||||||||||||
accrued product returns and rebates | 189,720,000 | 161,097,000 | 184,459,000 | 180,916,000 | 170,133,000 | 168,705,000 | 169,124,000 | 175,119,000 | 167,226,000 | 154,274,000 | 162,473,000 | 148,826,000 | 147,852,000 | 151,665,000 | 158,470,000 | 145,761,000 | 140,181,000 | 132,724,000 | 132,048,000 | 173,598,000 | 128,736,000 | 126,192,000 | 136,973,000 | 144,105,000 | 119,453,000 | 107,629,000 | 98,050,000 | 95,934,000 | 88,200,000 | |||||||||||||||||||||
contingent consideration, current portion | 31,052,000 | 11,235,000 | 30,000,000 | 47,340,000 | 46,581,000 | 47,303,000 | 51,379,000 | 52,070,000 | 45,880,000 | 20,720,000 | 21,120,000 | 47,590,000 | 47,240,000 | 46,890,000 | 44,840,000 | 23,570,000 | 23,540,000 | 31,520,000 | 30,900,000 | 82,900,000 | 23,500,000 | |||||||||||||||||||||||||||||
other current liabilities | 82,965,000 | 38,222,000 | 26,322,000 | 27,705,000 | 4,748,000 | 3,623,000 | 9,547,000 | 4,283,000 | 710,000 | 7,485,000 | 16,863,000 | 8,187,000 | 8,626,000 | 8,055,000 | 20,132,000 | 6,807,000 | 6,316,000 | 10,457,000 | 9,082,000 | |||||||||||||||||||||||||||||||
total current liabilities | 373,929,000 | 338,171,000 | 330,629,000 | 286,360,000 | 281,772,000 | 292,397,000 | 291,508,000 | 308,656,000 | 314,554,000 | 290,196,000 | 287,534,000 | 252,590,000 | 731,545,000 | 687,958,000 | 725,987,000 | 735,536,000 | 284,558,000 | 315,379,000 | 234,711,000 | 283,447,000 | 240,812,000 | 245,108,000 | 299,606,000 | 269,276,000 | 168,335,000 | 160,587,000 | 149,717,000 | 143,971,000 | 151,706,000 | 138,346,000 | 103,934,000 | 119,088,000 | 104,956,000 | 85,524,000 | 82,003,000 | 71,647,000 | 65,572,000 | 54,124,000 | 43,128,000 | 36,414,000 | 26,855,000 | 22,126,000 | 19,187,000 | 27,102,000 | 25,071,000 | 16,024,000 | 27,008,000 | 24,590,000 | 21,881,000 | 19,912,000 |
contingent consideration, long-term | 206,000 | 206,000 | 213,000 | 403,000 | 697,000 | 976,000 | 7,774,000 | 33,390,000 | 53,320,000 | 9,781,000 | 9,645,000 | 9,252,000 | ||||||||||||||||||||||||||||||||||||||
operating lease liabilities, long-term | 30,267,000 | 30,365,000 | 31,422,000 | 24,383,000 | 26,368,000 | 27,382,000 | 28,926,000 | 30,294,000 | 32,994,000 | 33,841,000 | 34,177,000 | 36,511,000 | 36,028,000 | 37,080,000 | 39,891,000 | |||||||||||||||||||||||||||||||||||
other liabilities | 19,518,000 | 22,192,000 | 7,823,000 | 7,762,000 | 7,464,000 | 7,600,000 | 7,350,000 | 7,288,000 | 6,899,000 | 6,422,000 | 8,596,000 | 8,734,000 | 8,614,000 | 8,692,000 | 10,371,000 | 11,965,000 | 14,145,000 | 16,380,000 | 18,186,000 | 19,092,000 | 39,675,000 | 42,791,000 | 9,304,000 | 9,560,000 | 9,743,000 | 9,409,000 | 11,211,000 | 10,955,000 | ||||||||||||||||||||||
total liabilities | 423,920,000 | 390,934,000 | 370,087,000 | 318,505,000 | 316,585,000 | 332,340,000 | 335,551,000 | 358,375,000 | 374,924,000 | 356,157,000 | 372,969,000 | 373,191,000 | 879,658,000 | 816,304,000 | 840,331,000 | 853,539,000 | 811,071,000 | 873,301,000 | 744,572,000 | 787,481,000 | 752,999,000 | 759,244,000 | 801,143,000 | 825,046,000 | 576,483,000 | 564,854,000 | 549,652,000 | 540,771,000 | 545,430,000 | 500,576,000 | 462,307,000 | 473,291,000 | 133,815,000 | 116,973,000 | 116,192,000 | 111,745,000 | 77,611,000 | 66,335,000 | 57,334,000 | 51,803,000 | 45,053,000 | 60,206,000 | 60,821,000 | 68,507,000 | 111,312,000 | 96,081,000 | 37,789,000 | 42,383,000 | 41,985,000 | 42,928,000 |
commitments and contingencies | ||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, 0.001 par value... | 58,000 | 57,000 | 57,000 | 56,000 | 56,000 | 56,000 | 55,000 | 55,000 | 55,000 | 55,000 | 55,000 | 55,000 | 54,000 | 54,000 | 54,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 53,000 | 52,000 | 52,000 | 52,000 | 52,000 | 52,000 | 52,000 | 51,000 | 51,000 | 50,000 | 50,000 | 50,000 | 49,000 | 49,000 | 48,000 | 48,000 | 43,000 | 42,000 | 42,000 | ||||||
additional paid-in capital | 561,419,000 | 543,825,000 | 527,700,000 | 496,946,000 | 486,209,000 | 479,440,000 | 465,919,000 | 455,170,000 | 446,960,000 | 439,493,000 | 431,956,000 | 424,266,000 | 416,232,000 | 408,115,000 | 401,026,000 | 389,586,000 | 383,016,000 | 434,337,000 | 428,726,000 | 424,175,000 | 415,950,000 | 409,332,000 | 403,396,000 | 398,829,000 | 392,430,000 | 388,410,000 | 383,525,000 | 379,369,000 | 373,707,000 | 365,396,000 | 361,971,000 | 352,257,000 | 291,841,000 | 285,572,000 | 279,792,000 | 271,801,000 | 270,059,000 | 267,576,000 | 261,006,000 | 258,202,000 | 252,341,000 | 229,123,000 | 224,196,000 | 223,041,000 | 168,625,000 | 168,122,000 | 145,999,000 | 97,378,000 | 97,209,000 | 49,462,000 |
accumulated other comprehensive loss, net of tax | -255,000 | -44,000 | -71,000 | -200,000 | -159,000 | -189,000 | -372,000 | -534,000 | -1,206,000 | -1,775,000 | -2,329,000 | |||||||||||||||||||||||||||||||||||||||
retained earnings | 515,583,000 | 517,876,000 | 521,981,000 | 567,098,000 | 544,599,000 | 556,426,000 | 541,098,000 | 502,601,000 | 482,685,000 | 482,561,000 | 481,386,000 | 497,362,000 | 498,193,000 | 481,245,000 | 455,764,000 | 454,015,000 | 446,150,000 | 379,922,000 | 377,480,000 | 355,918,000 | 332,192,000 | 326,498,000 | 295,730,000 | 255,733,000 | 221,066,000 | 199,548,000 | 166,419,000 | 137,559,000 | 104,832,000 | 60,599,000 | 32,588,000 | 1,851,000 | ||||||||||||||||||
total stockholders' equity | 1,076,805,000 | 1,061,714,000 | 1,049,667,000 | 1,063,900,000 | 12,453,000 | 35,892,000 | ||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders' equity | 1,500,725,000 | 1,452,648,000 | 1,419,754,000 | 1,382,405,000 | 123,765,000 | 131,973,000 | ||||||||||||||||||||||||||||||||||||||||||||
deferred income tax liabilities | 981,000 | 4,961,000 | 7,364,000 | 11,440,000 | 19,501,000 | 24,963,000 | 35,224,000 | 44,300,000 | 49,668,000 | 49,809,000 | 58,164,000 | 59,313,000 | 62,843,000 | 85,355,000 | 34,146,000 | 32,986,000 | 31,742,000 | 35,215,000 | 37,941,000 | 35,716,000 | ||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity | ||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity | 1,030,705,000 | 1,035,733,000 | 1,007,150,000 | 957,454,000 | 929,166,000 | 921,516,000 | 912,191,000 | 919,908,000 | 912,150,000 | 886,204,000 | 852,798,000 | 841,434,000 | 828,446,000 | 815,851,000 | 810,468,000 | 785,579,000 | 754,444,000 | 744,858,000 | 708,879,000 | 665,974,000 | 613,383,000 | 595,428,000 | 557,257,000 | 522,904,000 | 480,018,000 | 421,936,000 | 390,492,000 | 351,869,000 | 251,663,000 | 229,397,000 | 206,064,000 | 173,371,000 | 141,022,000 | 128,139,000 | 109,436,000 | 102,365,000 | 94,584,000 | 66,119,000 | 33,369,000 | 29,013,000 | 41,272,000 | 24,631,000 | 37,980,000 | 274,000 | ||||||
total liabilities and stockholders’ equity | 1,347,290,000 | 1,368,073,000 | 1,342,701,000 | 1,315,829,000 | 1,304,090,000 | 1,277,673,000 | 1,285,160,000 | 1,293,099,000 | 1,791,808,000 | 1,702,508,000 | 1,693,129,000 | 1,694,973,000 | 1,639,517,000 | 1,689,152,000 | 1,555,040,000 | 1,573,060,000 | 1,507,443,000 | 1,504,102,000 | 1,510,022,000 | 1,491,020,000 | 1,189,866,000 | 1,160,282,000 | 1,106,909,000 | 1,063,675,000 | 1,025,448,000 | 922,512,000 | 852,799,000 | 825,160,000 | 385,478,000 | 346,370,000 | 322,256,000 | 285,116,000 | 218,633,000 | 194,474,000 | 166,770,000 | 154,168,000 | 139,637,000 | 126,325,000 | 94,190,000 | 97,520,000 | 79,061,000 | 67,014,000 | 79,965,000 | 43,202,000 | ||||||
long-term marketable securities | 11,662,000 | 25,125,000 | 37,478,000 | 54,157,000 | 131,937,000 | 147,373,000 | 125,337,000 | |||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive earnings, net of tax | 78,000 | -593,000 | -3,210,000 | -4,046,000 | -2,220,000 | -773,000 | 1,539,000 | 4,209,000 | 5,433,000 | 6,249,000 | 8,975,000 | 9,700,000 | 11,359,000 | -166,000 | 7,417,000 | 7,261,000 | 5,924,000 | 1,427,000 | ||||||||||||||||||||||||||||||||
long term marketable securities | 16,617,000 | 93,896,000 | 119,166,000 | 405,479,000 | 445,473,000 | 416,566,000 | 350,359,000 | 388,185,000 | 358,673,000 | 534,712,000 | 591,773,000 | 596,442,000 | 593,754,000 | 522,551,000 | 460,304,000 | 503,312,000 | 175,064,000 | 123,123,000 | 104,632,000 | 89,163,000 | 67,044,000 | 67,809,000 | 68,790,000 | 43,967,000 | 33,488,000 | 27,315,000 | 15,763,000 | 15,462,000 | 11,662,000 | |||||||||||||||||||||
convertible notes | 402,500,000 | 401,968,000 | 401,438,000 | 400,909,000 | 400,382,000 | 379,252,000 | 374,788,000 | 370,383,000 | 366,038,000 | 361,751,000 | 357,521,000 | 353,349,000 | 349,232,000 | 345,170,000 | 341,163,000 | 337,210,000 | 333,310,000 | 325,666,000 | 321,920,000 | 318,225,000 | 1,472,000 | 3,310,000 | 5,772,000 | 5,699,000 | 5,627,000 | |||||||||||||||||||||||||
contingent consideration, long term | 1,380,000 | 33,847,000 | 35,637,000 | 45,480,000 | 45,430,000 | 46,200,000 | 45,800,000 | 33,000,000 | 92,200,000 | |||||||||||||||||||||||||||||||||||||||||
operating lease liabilities, long term | 33,196,000 | 35,998,000 | 41,298,000 | 37,261,000 | 36,143,000 | 28,532,000 | 28,579,000 | 29,522,000 | 30,108,000 | |||||||||||||||||||||||||||||||||||||||||
line of credit | 78,363,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | 34,067,000 | 32,063,000 | 27,953,000 | 25,975,000 | 27,967,000 | 31,367,000 | 25,528,000 | 26,254,000 | 28,807,000 | 30,449,000 | 37,863,000 | |||||||||||||||||||||||||||||||||||||||
operating lease assets | 21,019,000 | 21,289,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
finance lease asset | 21,676,000 | 22,479,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 11,193,000 | 5,515,000 | 3,124,000 | 10,141,000 | 3,090,000 | 4,081,000 | 7,240,000 | 9,838,000 | 2,943,000 | 3,333,000 | 6,262,000 | 7,577,000 | 5,056,000 | 2,685,000 | 2,243,000 | 2,646,000 | 2,812,000 | 4,518,000 | 859,000 | |||||||||||||||||||||||||||||||
accrued expenses and other current liabilities | 56,289,000 | 58,818,000 | 33,003,000 | 37,130,000 | 40,800,000 | 38,614,000 | 36,607,000 | |||||||||||||||||||||||||||||||||||||||||||
income taxes payable | 25,052,000 | 9,097,000 | 2,443,000 | 4,818,000 | 2,674,000 | 17,233,000 | 8,548,000 | 16,265,000 | 6,489,000 | |||||||||||||||||||||||||||||||||||||||||
operating lease liabilities, current portion | 3,741,000 | 3,560,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
finance lease liability, current portion | 3,612,000 | 4,201,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
nonrecourse liability related to sale of future royalties, current portion | 4,898,000 | 4,525,000 | 3,658,000 | 2,959,000 | ||||||||||||||||||||||||||||||||||||||||||||||
nonrecourse liability related to sale of future royalties, long term | 14,960,000 | 16,455,000 | 18,369,000 | 20,305,000 | ||||||||||||||||||||||||||||||||||||||||||||||
finance lease liability, long term | 19,289,000 | 18,382,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
lease assets | 21,911,000 | 21,279,000 | 18,780,000 | 19,639,000 | 20,049,000 | |||||||||||||||||||||||||||||||||||||||||||||
lease liabilities, long term | 30,804,000 | 30,440,000 | 27,256,000 | 27,535,000 | 27,824,000 | |||||||||||||||||||||||||||||||||||||||||||||
nonrecourse liability related to sale of future royalties; current portion | 3,244,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
nonrecourse liability related to sale of future royalties; long term | 19,248,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
non-recourse liability related to sale of future royalties, current portion | 2,668,000 | 2,426,000 | 1,892,000 | 1,659,000 | 1,432,000 | 5,254,000 | 4,997,000 | 4,645,000 | ||||||||||||||||||||||||||||||||||||||||||
non-recourse liability related to sale of future royalties, long term | 21,100,000 | 21,957,000 | 23,305,000 | 23,867,000 | 24,370,000 | 22,702,000 | 24,184,000 | 25,555,000 | ||||||||||||||||||||||||||||||||||||||||||
other non-current liabilities | 10,633,000 | 13,259,000 | 12,586,000 | 11,608,000 | 4,936,000 | 4,500,000 | 3,936,000 | 4,199,000 | 4,322,000 | 4,391,000 | 3,815,000 | 3,355,000 | 2,561,000 | 3,015,000 | 2,784,000 | 2,101,000 | 2,401,000 | 2,158,000 | 1,860,000 | 1,558,000 | 1,432,000 | 1,382,000 | ||||||||||||||||||||||||||||
other non-current assets | 782,000 | 752,000 | 735,000 | 368,000 | 349,000 | 350,000 | 332,000 | 320,000 | 311,000 | 415,000 | 435,000 | 497,000 | 360,000 | 361,000 | 360,000 | |||||||||||||||||||||||||||||||||||
accrued sales deductions | 85,970,000 | 70,044,000 | 73,034,000 | 59,772,000 | 47,621,000 | 43,450,000 | 39,694,000 | 35,019,000 | 28,697,000 | 18,820,000 | ||||||||||||||||||||||||||||||||||||||||
accrued expenses | 32,098,000 | 29,288,000 | 25,024,000 | 26,892,000 | 23,434,000 | 26,890,000 | 26,719,000 | 28,102,000 | 22,573,000 | 21,353,000 | 31,753,000 | 25,853,000 | ||||||||||||||||||||||||||||||||||||||
deferred licensing revenue | 287,000 | 287,000 | 287,000 | 207,000 | 208,000 | 208,000 | 143,000 | 143,000 | 143,000 | 143,000 | 143,000 | 173,000 | 234,000 | 325,000 | 417,000 | |||||||||||||||||||||||||||||||||||
deferred licensing revenue, net of current portion | 1,221,000 | 1,293,000 | 1,365,000 | 1,554,000 | 1,606,000 | 1,658,000 | 1,167,000 | 1,202,000 | 1,238,000 | 1,310,000 | 1,345,000 | 1,381,000 | 1,452,000 | 738,000 | 774,000 | |||||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
derivative liabilities | 23,000 | 287,000 | 412,000 | 535,000 | 1,156,000 | 2,070,000 | 2,691,000 | 7,258,000 | 8,834,000 | 9,565,000 | 22,213,000 | 18,061,000 | ||||||||||||||||||||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income, net of tax | 252,000 | 216,000 | 32,000 | |||||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -156,122,000 | -132,026,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
deferred legal fees | 11,887,000 | 11,331,000 | 17,437,000 | 16,386,000 | 11,444,000 | |||||||||||||||||||||||||||||||||||||||||||||
accrued income taxes payable | 1,608,000 | 1,675,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax asset | 42,256,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
non-recourse liability related to sale of future royalties-current portion | 2,342,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
non-recourse liability related to sale of future royalties-long term | 28,286,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income, net of tax benefit | 127,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | 549,000 | 168,000 | 1,000 | 1,000 | -235,000 | 6,000 | 8,000 | |||||||||||||||||||||||||||||||||||||||||||
convertible notes, net of discount | 8,068,000 | 8,762,000 | 11,708,000 | 26,497,000 | 28,671,000 | 28,358,000 | 60,175,000 | 59,100,000 | ||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -81,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
interest receivable | 493,000 | 496,000 | 636,000 | 982,000 | 791,000 | 672,000 | ||||||||||||||||||||||||||||||||||||||||||||
deferred financing costs, current | 166,000 | 202,000 | 185,000 | 431,000 | 430,000 | 144,000 | 144,000 | 144,000 | 144,000 | |||||||||||||||||||||||||||||||||||||||||
deferred financing costs, long-term | 599,000 | 713,000 | 764,000 | 2,031,000 | 2,109,000 | 53,000 | 142,000 | 161,000 | 2,686,000 | |||||||||||||||||||||||||||||||||||||||||
accounts payable and accrued expenses | 21,983,000 | 19,044,000 | 14,658,000 | 14,472,000 | 11,732,000 | 10,903,000 | 10,485,000 | 9,175,000 | 9,337,000 | |||||||||||||||||||||||||||||||||||||||||
deferred product revenue | 12,271,000 | 10,365,000 | 3,967,000 | 3,551,000 | ||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other | 1,815,000 | 1,912,000 | 861,000 | 1,276,000 | 1,010,000 | 618,000 | ||||||||||||||||||||||||||||||||||||||||||||
long term investments | 15,215,000 | 16,072,000 | 1,804,000 | |||||||||||||||||||||||||||||||||||||||||||||||
secured notes payable, net of discount | 12,137,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
secured notes payable, net of current portion and discount | 7,975,000 | 14,116,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
stockholders' equity: | ||||||||||||||||||||||||||||||||||||||||||||||||||
2013 and december 31, 2012; 30,945,205 and 30,621,869 shares issued and | ||||||||||||||||||||||||||||||||||||||||||||||||||
outstanding at september 30, 2013 and december 31, 2012, respectively | 31,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
purchased patents | 568,000 | 626,000 | 740,000 | 798,000 | 855,000 | |||||||||||||||||||||||||||||||||||||||||||||
2013 and december 31, 2012; 30,940,330 and 30,621,869 shares issued and | ||||||||||||||||||||||||||||||||||||||||||||||||||
outstanding at june 30, 2013 and december 31, 2012, respectively | 31,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
warrant liability | 172,000 | 1,463,000 | 1,169,000 | 1,025,000 | ||||||||||||||||||||||||||||||||||||||||||||||
series a preferred stock, 0.001par value - 65,000,000 shares authorized at march 31, 2013 and december 31, 2012; zero shares issued and outstanding at march 31, 2013 and december 31, 2012 | ||||||||||||||||||||||||||||||||||||||||||||||||||
common stock | 31,000 | 24,000 | 24,000 | 2,000 | ||||||||||||||||||||||||||||||||||||||||||||||
marketable securities - restricted | 275,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
inventory | 26,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
accrued compensation | 1,801,000 | 1,335,000 | 901,000 | |||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue | 576,000 | 365,000 | 232,000 | |||||||||||||||||||||||||||||||||||||||||||||||
interest payable | 238,000 | 259,000 | 271,000 | |||||||||||||||||||||||||||||||||||||||||||||||
secured notes payable | 11,490,000 | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue, net of current portion | 381,000 | 183,000 | 407,000 | |||||||||||||||||||||||||||||||||||||||||||||||
supplemental executive retirement plan | 275,000 | 259,000 | 276,000 | |||||||||||||||||||||||||||||||||||||||||||||||
series a convertible preferred stock, 0.001 par value - 49,625,000 shares and 65,000,000 shares authorized at december 31, 2011 and september 30, 2012, respectively; 49,000,000 shares issued and outstanding at december 31, 2011 and zero shares issued and outstanding as of september 30, 2012, respectively; aggregate liquidation preference of 69,520 and zero at december 31, 2011 and september 30, 2012, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||
marketable securities—restricted | 259,000 | 276,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
secured notes payable, current | 10,747,000 | 9,171,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
secured notes payable, net of current portion | 17,061,000 | 19,926,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
series a convertible preferred stock, 0.001 par value—49,625,000 shares and 65,000,000 shares authorized at december 31, 2011 and june 30, 2012 respectively; 49,000,000 shares issued and outstanding at december 31, 2011 and 0 shares issued and outstanding at june 30, 2012; aggregate liquidation preference of 69,520 and zero at december 31, 2011 and june 30, 2012, respectively | ||||||||||||||||||||||||||||||||||||||||||||||||||
series a convertible preferred stock, 0.001 par value—49,625,000 shares authorized at december 31, 2011 and march 31, 2012; 49,000,000 shares issued and outstanding at december 31, 2011 and march 31, 2012; aggregate liquidation preference of 69,520 and 70,378 at december 31, 2011 and march 31, 2012, respectively | 49,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||
net loss | -2,293,000 | 3,201,000 | -15,543,000 | -24,096,000 | -27,357,000 | -18,414,000 | -13,483,000 | -10,011,000 | -9,277,000 | ||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 26,132,000 | 66,547,000 | 21,358,000 | 20,383,000 | 18,845,000 | 20,102,000 | 20,718,000 | 20,749,000 | 21,676,000 | 21,857,000 | 20,725,000 | 20,601,000 | 20,849,000 | 21,775,000 | 21,557,000 | 21,362,000 | 12,707,000 | 6,675,000 | 6,621,000 | 6,592,000 | 5,520,000 | 7,577,000 | 3,312,000 | 1,732,000 | 1,630,000 | 1,674,000 | 1,676,000 | 1,679,000 | 1,884,000 | 1,780,000 | 1,707,000 | 4,378,000 | 1,343,000 | 741,000 | 611,000 | 688,000 | 429,000 | 220,000 | 217,000 | 214,000 | 241,000 | 233,000 | 227,000 | 200,000 | 164,000 | 162,000 | 212,000 | 213,000 | 225,000 |
amortization of premium/discount on marketable securities | -192,000 | -2,027,000 | -32,000 | -1,074,000 | -674,000 | 966,000 | -363,000 | 1,894,000 | 727,000 | 68,000 | 139,000 | -1,056,000 | 18,000 | 2,147,000 | 1,428,000 | -360,000 | 1,263,000 | 1,526,000 | -665,000 | -1,706,000 | 328,000 | -4,201,000 | 1,435,000 | -451,000 | -1,146,000 | -1,564,000 | 89,000 | ||||||||||||||||||||||
change in fair value of contingent consideration | 2,391,000 | 7,660,000 | 0 | 7,660,000 | 356,000 | -1,016,000 | -4,355,000 | -1,095,000 | -456,000 | 790,000 | -1,647,000 | 486,000 | 743,000 | 665,000 | 80,000 | -8,750,000 | 1,020,000 | ||||||||||||||||||||||||||||||||
realized loss from sale of marketable securities | -21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
share-based compensation expense | 8,480,000 | 23,400,000 | 7,507,000 | 8,068,000 | 7,632,000 | 7,674,000 | 6,552,000 | 5,897,000 | 6,445,000 | 7,920,000 | 6,088,000 | 6,306,000 | 4,261,000 | 4,985,000 | 4,297,000 | 4,025,000 | 4,036,000 | 4,027,000 | 5,476,000 | 4,371,000 | 3,121,000 | 4,490,000 | 4,962,000 | 3,988,000 | 3,623,000 | 3,914,000 | 4,022,000 | 3,287,000 | 2,597,000 | 3,068,000 | 2,635,000 | 2,360,000 | 2,260,000 | 1,827,000 | 1,483,000 | 1,612,000 | 1,359,000 | 1,132,000 | 1,119,000 | 901,000 | |||||||||
deferred income tax expense | 5,916,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
noncash lease expense | 2,258,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
inventory valuation write-down | 1,815,000 | 1,228,000 | 920,000 | 547,000 | |||||||||||||||||||||||||||||||||||||||||||||
payment of contingent consideration | -4,900,000 | 0 | -4,900,000 | 0 | 0 | 0 | -22,900,000 | ||||||||||||||||||||||||||||||||||||||||||
other noncash adjustments | 284,000 | 7,606,000 | 1,953,000 | 1,826,000 | -756,000 | 1,658,000 | 4,174,000 | 2,449,000 | 3,435,000 | 2,058,000 | 5,968,000 | 2,459,000 | 3,655,000 | 9,170,000 | -1,271,000 | 84,000 | -1,398,000 | 629,000 | 551,000 | -1,202,000 | |||||||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||
accounts receivable | 5,619,000 | -5,885,000 | 4,809,000 | -3,563,000 | 3,331,000 | 7,086,000 | -4,760,000 | -3,579,000 | -2,390,000 | -5,209,000 | 4,393,000 | 21,971,000 | -1,408,000 | -5,865,000 | -12,905,000 | 3,812,000 | -3,485,000 | 3,747,000 | -10,200,000 | 13,805,000 | -7,767,000 | -6,409,000 | 11,392,000 | -31,823,000 | -593,000 | -2,095,000 | -4,574,000 | 23,013,000 | 2,642,000 | -6,671,000 | |||||||||||||||||||
inventories | -105,000 | -3,322,000 | 4,887,000 | 4,731,000 | 3,187,000 | 4,604,000 | 6,025,000 | 1,990,000 | 5,028,000 | 6,912,000 | -3,979,000 | -1,851,000 | -11,554,000 | -8,146,000 | 4,310,000 | -2,468,000 | -5,249,000 | -1,381,000 | -6,902,000 | -1,048,000 | -4,687,000 | -7,126,000 | -521,000 | 2,210,000 | -1,124,000 | 520,000 | 1,676,000 | ||||||||||||||||||||||
prepaid expenses and other assets | -12,432,000 | -6,274,000 | -2,502,000 | 7,372,000 | -10,810,000 | -1,753,000 | 728,000 | -7,517,000 | 7,804,000 | 20,406,000 | -28,203,000 | -341,000 | 9,205,000 | 1,232,000 | 805,000 | 1,061,000 | 4,953,000 | 4,652,000 | -17,635,000 | -368,000 | -929,000 | 1,729,000 | 260,000 | 38,000 | 96,000 | -1,051,000 | 133,000 | ||||||||||||||||||||||
accrued product returns and rebates | 28,623,000 | 15,754,000 | 10,783,000 | 1,428,000 | -419,000 | -5,995,000 | 7,893,000 | 12,952,000 | -8,199,000 | 13,647,000 | 974,000 | -3,813,000 | -6,805,000 | 12,709,000 | 5,580,000 | 7,457,000 | -1,354,000 | -41,550,000 | 44,862,000 | 2,544,000 | -10,780,000 | -7,132,000 | 16,474,000 | 11,824,000 | 9,579,000 | 2,116,000 | |||||||||||||||||||||||
accounts payable and other liabilities | 49,000 | -24,075,000 | -6,485,000 | 3,938,000 | -418,000 | -11,827,000 | -12,789,000 | 10,019,000 | -269,000 | -6,086,000 | -19,384,000 | -10,548,000 | -6,504,000 | -24,422,000 | 41,242,000 | -29,479,000 | 33,905,000 | -10,047,000 | 4,329,000 | -10,008,000 | |||||||||||||||||||||||||||||
net cash from operating activities | 66,524,000 | 27,470,000 | 58,535,000 | 30,599,000 | 44,406,000 | 53,520,000 | 35,624,000 | 38,401,000 | 44,958,000 | 35,875,000 | -18,874,000 | 49,126,000 | 27,564,000 | 13,841,000 | 71,119,000 | 4,302,000 | 48,763,000 | -4,110,000 | 46,274,000 | 36,200,000 | 31,933,000 | 5,599,000 | 91,951,000 | 8,916,000 | 43,791,000 | 37,658,000 | -2,983,000 | 14,669,000 | 503,000 | -15,550,000 | |||||||||||||||||||
capital expenditures | -911,000 | -455,000 | -327,000 | -213,000 | -200,000 | -64,000 | -248,000 | 0 | -150,000 | -159,000 | -278,000 | 10,000 | -147,000 | 0 | -851,000 | -40,000 | 0 | 0 | -1,508,000 | -215,000 | -162,000 | -535,000 | -2,537,000 | -2,029,000 | -462,000 | 0 | 0 | 0 | -377,000 | ||||||||||||||||||||
free cash flows | 26,559,000 | 58,080,000 | 30,272,000 | 44,193,000 | 53,320,000 | 35,560,000 | 38,153,000 | 44,958,000 | 35,725,000 | -19,033,000 | 48,848,000 | 27,574,000 | 13,694,000 | 71,119,000 | 3,451,000 | 48,723,000 | -4,110,000 | 46,274,000 | 34,692,000 | 31,718,000 | 5,437,000 | 91,416,000 | 6,379,000 | 41,762,000 | 37,196,000 | -2,983,000 | 14,669,000 | 503,000 | -15,927,000 | ||||||||||||||||||||
cash flows from investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
purchases of marketable securities | -78,438,000 | -385,741,000 | -140,556,000 | -118,557,000 | -145,405,000 | -224,928,000 | -123,980,000 | -193,700,000 | -66,325,000 | -134,162,000 | -108,440,000 | -98,063,000 | -3,939,000 | -74,362,000 | -114,209,000 | -119,063,000 | -8,000,000 | -72,508,000 | 0 | -15,382,000 | -48,586,000 | -96,195,000 | -17,964,000 | ||||||||||||||||||||||||||
maturities of marketable securities | 59,220,000 | 735,161,000 | 110,404,000 | 156,201,000 | 132,980,000 | 148,117,000 | |||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment | -911,000 | -455,000 | -327,000 | -213,000 | -200,000 | -64,000 | -248,000 | -150,000 | -159,000 | -278,000 | 0 | -1,508,000 | -215,000 | -162,000 | -535,000 | -2,537,000 | -2,029,000 | -462,000 | -377,000 | ||||||||||||||||||||||||||||||
net cash from investing activities | -19,218,000 | 55,416,000 | -30,607,000 | 37,317,000 | -12,638,000 | -77,011,000 | -48,594,000 | -51,624,000 | -65,981,000 | 34,634,000 | 60,296,000 | 239,780,000 | -48,765,000 | -82,232,000 | -15,679,000 | -69,987,000 | 76,130,000 | -5,704,000 | -80,894,000 | -71,445,000 | 49,345,000 | -11,302,000 | -108,180,000 | 35,438,000 | 19,438,000 | -8,355,000 | -973,000 | 4,606,000 | |||||||||||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock | 13,670,000 | 29,059,000 | 3,276,000 | 2,042,000 | 6,877,000 | 3,462,000 | 1,659,000 | 2,910,000 | 3,082,000 | -230,000 | 1,947,000 | 1,811,000 | 2,829,000 | 6,455,000 | 2,273,000 | 866,000 | 1,575,000 | 524,000 | 2,749,000 | 2,247,000 | 2,815,000 | 77,000 | 1,437,000 | 32,000 | 1,263,000 | 242,000 | 1,640,000 | 783,000 | 828,000 | 6,646,000 | 2,857,000 | 2,346,000 | 1,560,000 | 604,000 | 260,000 | 871,000 | 124,000 | 58,000 | 862,000 | 147,000 | 14,000 | 245,000 | 6,000 | 11,000 | 217,000 | 1,936,000 | 49,000 | ||
employee taxes paid related to net share settlement of equity awards | -4,555,000 | -4,198,000 | -46,000 | -3,341,000 | -987,000 | -387,000 | -1,000 | -1,340,000 | |||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | 9,115,000 | 604,000 | 935,000 | -21,399,000 | 5,890,000 | 3,075,000 | 1,658,000 | 1,570,000 | 1,092,000 | -230,000 | -478,916,000 | 80,174,000 | 2,829,000 | 6,455,000 | 2,273,000 | -22,034,000 | -136,740,000 | 1,324,000 | 2,749,000 | 2,247,000 | 3,069,000 | -979,000 | 1,437,000 | 32,000 | 1,263,000 | 242,000 | 58,000 | 862,000 | 147,000 | 14,000 | 245,000 | 5,000 | -18,000 | ||||||||||||||||
net change in cash, cash equivalents, and restricted cash | 56,421,000 | 83,490,000 | -11,653,000 | -437,494,000 | 369,080,000 | ||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | 129,898,000 | 69,331,000 | 0 | 69,331,000 | 0 | 0 | 0 | 75,054,000 | 0 | 0 | 0 | 93,120,000 | 0 | 0 | 0 | 203,434,000 | 0 | 0 | 0 | 288,640,000 | 0 | 0 | 0 | 181,381,000 | 0 | 0 | 0 | 192,248,000 | 0 | 0 | 100,304,000 | ||||||||||||||||||
cash, cash equivalents, and restricted cash at end of year | 186,319,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
reconciliation of cash, cash equivalents, and restricted cash reported in the condensed consolidated balance sheets | |||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 184,869,000 | 151,371,000 | |||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 1,450,000 | 1,450,000 | |||||||||||||||||||||||||||||||||||||||||||||||
total cash, cash equivalents, and restricted cash shown in the statement of cash flows | 186,319,000 | 152,821,000 | |||||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow information | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid (refund received) for income taxes | -412,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
net earnings | -34,445,000 | 22,499,000 | -11,827,000 | 15,328,000 | 38,497,000 | 19,916,000 | 124,000 | 1,175,000 | -15,976,000 | -831,000 | 16,948,000 | 25,481,000 | 1,749,000 | 7,865,000 | 25,616,000 | 2,442,000 | 21,562,000 | 23,726,000 | 5,694,000 | 30,768,000 | 39,997,000 | 34,667,000 | 21,518,000 | 33,129,000 | 28,860,000 | 32,727,000 | 18,340,000 | 28,011,000 | 30,737,000 | 26,352,000 | |||||||||||||||||||
adjustments to reconcile net earnings to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
intangible asset impairment charges | |||||||||||||||||||||||||||||||||||||||||||||||||
amortization of deferred financing costs and debt discount | 0 | 0 | 0 | 532,000 | 530,000 | 529,000 | 527,000 | 526,000 | 4,464,000 | 4,405,000 | 4,345,000 | 4,287,000 | 4,230,000 | 4,172,000 | 4,118,000 | 4,061,000 | 4,007,000 | 3,953,000 | 3,900,000 | 3,848,000 | 3,745,000 | 3,695,000 | 612,000 | 122,000 | 150,000 | 374,000 | 512,000 | 513,000 | 574,000 | 1,183,000 | 804,000 | 83,000 | |||||||||||||||||
realized loss (gains) from sales of marketable securities | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax benefit | -13,797,000 | -7,162,000 | -3,990,000 | -72,000 | -6,467,000 | -8,115,000 | -5,482,000 | -10,459,000 | -9,266,000 | -5,554,000 | -435,000 | -13,011,000 | 2,782,000 | -3,600,000 | 538,000 | 4,258,000 | |||||||||||||||||||||||||||||||||
acquisition of sage, net of cash acquired | -293,093,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from credit line | |||||||||||||||||||||||||||||||||||||||||||||||||
payments on credit line | |||||||||||||||||||||||||||||||||||||||||||||||||
payment on convertible notes | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
reconciliation of cash, cash equivalents, and restricted cash reported in the consolidated balance sheets | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for income taxes | 15,780,000 | 12,423,000 | 274,000 | 12,911,000 | 19,581,000 | 20,426,000 | 336,000 | 9,547,000 | 6,621,000 | 20,231,000 | 203,000 | 6,015,000 | 8,065,000 | 478,000 | 4,415,000 | 20,395,000 | 301,000 | ||||||||||||||||||||||||||||||||
cash paid for interest on debt | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
realized gains from sales of marketable securities | 0 | 0 | -1,000 | -126,000 | -2,000 | -3,000 | -216,000 | -716,000 | -320,000 | ||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash at end of period | 152,821,000 | 63,401,000 | 462,200,000 | ||||||||||||||||||||||||||||||||||||||||||||||
net change in cash and cash equivalents | 28,863,000 | 46,517,000 | 37,658,000 | -20,416,000 | -19,931,000 | -18,372,000 | -61,936,000 | 57,713,000 | -87,719,000 | -11,847,000 | -8,490,000 | -31,871,000 | -32,998,000 | 84,347,000 | -6,682,000 | -14,792,000 | 44,386,000 | 64,492,000 | 29,545,000 | 343,836,000 | 18,803,000 | -10,962,000 | |||||||||||||||||||||||||||
cash and cash equivalents at end of period | 28,863,000 | 115,848,000 | -20,416,000 | 70,279,000 | -61,936,000 | 57,713,000 | 115,715,000 | -8,490,000 | -31,871,000 | 255,642,000 | 84,347,000 | -6,682,000 | -14,792,000 | 225,767,000 | 64,492,000 | 29,545,000 | -35,434,000 | 122,778,000 | 88,613,000 | -408,935,000 | 444,140,000 | 20,187,000 | 2,138,000 | 59,599,000 | 18,149,000 | 16,326,000 | 19,830,000 | -6,816,000 | 7,300,000 | 25,810,000 | 25,824,000 | -296,000 | 12,252,000 | -10,962,000 | 14,998,000 | 18,909,000 | -23,830,000 | 31,376,000 | 15,866,000 | ||||||||||
cash paid for operating leases | 3,892,000 | 5,086,000 | 4,136,000 | 4,002,000 | 3,870,000 | 4,533,000 | 5,252,000 | 3,457,000 | 3,336,000 | 3,309,000 | 3,289,000 | 2,949,000 | 4,295,000 | 3,577,000 | 2,202,000 | 1,834,000 | |||||||||||||||||||||||||||||||||
noncash investing and financing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
lease assets obtained for new operating leases | 22,000 | 921,000 | 2,604,000 | 1,965,000 | 1,337,000 | 2,601,000 | 761,000 | ||||||||||||||||||||||||||||||||||||||||||
other income from navitor | 0 | 0 | 0 | -12,888,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | |||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment additions from utilization of tenant improvement allowance | 0 | 0 | 31,000 | 549,000 | |||||||||||||||||||||||||||||||||||||||||||||
noncash operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||
sales and maturities of marketable securities | 142,324,000 | 35,604,000 | 34,784,000 | 60,455,000 | 240,058,000 | 17,550,000 | 52,077,000 | 92,185,000 | 28,927,000 | 377,963,000 | 68,702,000 | 34,265,000 | 49,579,000 | 59,001,000 | 61,485,000 | 204,579,000 | 53,357,000 | 68,703,000 | 88,302,000 | 49,022,000 | 47,143,000 | 25,805,000 | 12,123,000 | 7,343,000 | 10,633,000 | 7,279,000 | 5,140,000 | 6,740,000 | 8,258,000 | 7,400,000 | 11,809,000 | 13,131,000 | 8,731,000 | 14,894,000 | 17,997,000 | 9,096,000 | 23,253,000 | 11,547,000 | 12,866,000 | 9,742,000 | 7,381,000 | 293,000 | |||||||
noncash operating and investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
navitor investment r&d expense | 0 | 0 | 0 | 15,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
changes in fair value of contingent consideration | |||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration | 0 | 0 | 0 | -2,100,000 | |||||||||||||||||||||||||||||||||||||||||||||
acquisition of uswm, net of cash acquired | 0 | 0 | -1,341,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||
acquisition of adamas, net of cash acquired | |||||||||||||||||||||||||||||||||||||||||||||||||
distribution from navitor | |||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property and equipment and deferred legal fees paid | 10,000 | -147,000 | -40,000 | ||||||||||||||||||||||||||||||||||||||||||||||
proceeds from line of credit | 0 | 0 | 0 | 93,000,000 | |||||||||||||||||||||||||||||||||||||||||||||
payments on line of credit | 0 | 0 | -78,363,000 | -14,637,000 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from governmental loan and grant | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
repayment of acquired adamas loan | |||||||||||||||||||||||||||||||||||||||||||||||||
supplemental cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||||
noncash investing and financing activity: | |||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration liability related to acquisitions | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred legal fees and fixed assets included in accounts payable and accrued expenses | 160,000 | -139,000 | -13,000 | -343,000 | 708,000 | 1,337,000 | |||||||||||||||||||||||||||||||||||||||||||
cash paid for interest on convertible notes | 0 | 1,258,000 | 0 | 1,258,000 | 629,000 | 629,000 | 0 | 1,258,000 | 0 | 1,258,000 | 0 | 1,258,000 | 0 | 1,258,000 | 0 | 1,258,000 | |||||||||||||||||||||||||||||||||
deferred income tax provision | -7,760,000 | -2,507,000 | -4,515,000 | 1,567,000 | 519,000 | -2,565,000 | 1,642,000 | ||||||||||||||||||||||||||||||||||||||||||
distribution from (investment in) navitor | |||||||||||||||||||||||||||||||||||||||||||||||||
payments on finance lease liability | 254,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
income taxes paid | 283,000 | 324,000 | 15,607,000 | 11,138,000 | 23,995,000 | 800,000 | 651,000 | 23,656,000 | 5,623,000 | ||||||||||||||||||||||||||||||||||||||||
lease assets and tenant receivable obtained for new operating leases | 27,000 | 14,591,000 | 17,136,000 | ||||||||||||||||||||||||||||||||||||||||||||||
lease assets obtained for new finance lease | |||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property and equipment and deferred legal fees paid | -851,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
investment in navitor pharmaceuticals, inc. | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration liability accrued in uswm acquisition | 200,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
lease assets and tenant receivable obtained for new leases | 1,432,000 | 487,000 | |||||||||||||||||||||||||||||||||||||||||||||||
deferred legal fees | 0 | -453,000 | -100,000 | -117,000 | 1,350,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||
lease assets obtained for new leases | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of convertible notes | 0 | 0 | 402,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||
convertible notes issuance financing costs | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of warrants | 0 | 0 | 65,688,000 | ||||||||||||||||||||||||||||||||||||||||||||||
cash paid for biscayne acquisition | |||||||||||||||||||||||||||||||||||||||||||||||||
contingent consideration liability related to uswm acquisition | |||||||||||||||||||||||||||||||||||||||||||||||||
noncash interest expense | 1,645,000 | 1,504,000 | 1,366,000 | 1,444,000 | |||||||||||||||||||||||||||||||||||||||||||||
noncash royalty revenue | -2,402,000 | -2,351,000 | -1,567,000 | -1,899,000 | |||||||||||||||||||||||||||||||||||||||||||||
noncash operating lease cost | 757,000 | 851,000 | 991,000 | 966,000 | |||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | -4,551,000 | -4,313,000 | -454,000 | 1,513,000 | -655,000 | ||||||||||||||||||||||||||||||||||||||||||||
other noncurrent assets | -1,240,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 5,672,000 | -182,000 | -7,017,000 | 7,296,000 | -1,220,000 | -3,159,000 | 4,045,000 | -1,706,000 | |||||||||||||||||||||||||||||||||||||||||
accrued expenses and other current liabilities | -2,503,000 | 14,547,000 | -3,634,000 | -4,931,000 | 2,427,000 | ||||||||||||||||||||||||||||||||||||||||||||
income taxes payable | -25,051,000 | 15,859,000 | 6,654,000 | -2,375,000 | 2,144,000 | -14,559,000 | 4,856,000 | 327,000 | |||||||||||||||||||||||||||||||||||||||||
other liabilities | -758,000 | -1,711,000 | -1,020,000 | -3,185,000 | |||||||||||||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | 91,000 | 103,000 | 101,000 | 0 | 0 | 382,000 | 25,000 | 241,000 | 2,134,000 | 860,000 | 39,000 | 1,693,000 | 0 | ||||||||||||||||||||||||||||||||||||
change in fair value of derivative liability | -1,000 | 49,000 | |||||||||||||||||||||||||||||||||||||||||||||||
deferred licensing revenue | -53,000 | -52,000 | 300,000 | 623,000 | -127,000 | 373,000 | |||||||||||||||||||||||||||||||||||||||||||
purchases of convertible note hedges | |||||||||||||||||||||||||||||||||||||||||||||||||
conversion of convertible notes and interest make-whole | 1,562,000 | 1,961,000 | 1,023,000 | 0 | 0 | 2,138,000 | 963,000 | 3,880,000 | 21,176,000 | ||||||||||||||||||||||||||||||||||||||||
unsettled purchase of marketable securities included in accrued expenses | |||||||||||||||||||||||||||||||||||||||||||||||||
property and equipment acquired under build-to-suit lease transaction | |||||||||||||||||||||||||||||||||||||||||||||||||
interest capitalized during construction period for build-to-suit lease transaction | |||||||||||||||||||||||||||||||||||||||||||||||||
facility lease financing obligation | |||||||||||||||||||||||||||||||||||||||||||||||||
realized loss on sales of securities | |||||||||||||||||||||||||||||||||||||||||||||||||
amortization of operating lease assets | 351,000 | 879,000 | |||||||||||||||||||||||||||||||||||||||||||||||
non-cash interest expense | 1,414,000 | 1,437,000 | |||||||||||||||||||||||||||||||||||||||||||||||
non-cash royalty revenue | |||||||||||||||||||||||||||||||||||||||||||||||||
other non-current assets | |||||||||||||||||||||||||||||||||||||||||||||||||
other non-current liabilities | -1,783,000 | 889,000 | 984,000 | 417,000 | 73,000 | 230,000 | -13,000 | 434,000 | 44,000 | 125,000 | |||||||||||||||||||||||||||||||||||||||
cash paid for amounts included in the measurement of lease liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||
operating cash flows from operating leases | 1,391,000 | 1,313,000 | |||||||||||||||||||||||||||||||||||||||||||||||
non-cash investing and financing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred legal fees included in accounts payable and accrued expenses | 30,000 | 250,000 | -200,000 | 176,000 | 304,000 | -547,000 | -4,700,000 | 6,584,000 | 2,383,000 | 1,758,000 | 3,779,000 | ||||||||||||||||||||||||||||||||||||||
deferred income tax (benefit) provision | 279,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by operating activities | 32,993,000 | 62,448,000 | 6,556,000 | 27,133,000 | 39,005,000 | 28,239,000 | |||||||||||||||||||||||||||||||||||||||||||
net cash provided by financing activities | 783,000 | 828,000 | 6,646,000 | 367,713,000 | 2,346,000 | 1,560,000 | 604,000 | 260,000 | 871,000 | 124,000 | |||||||||||||||||||||||||||||||||||||||
non-cash interest expense on non-recourse liability related to sale of future royalties | 1,191,000 | 1,204,000 | 701,000 | 155,000 | 160,000 | 959,000 | |||||||||||||||||||||||||||||||||||||||||||
accrued sales deductions | 15,926,000 | -2,990,000 | 4,691,000 | 12,151,000 | 4,171,000 | 1,507,000 | |||||||||||||||||||||||||||||||||||||||||||
accrued expenses | 3,002,000 | 5,900,000 | 366,000 | ||||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest | 0 | 0 | 0 | 0 | 0 | 365,000 | 610,000 | ||||||||||||||||||||||||||||||||||||||||||
non-cash investing and financing activity: | |||||||||||||||||||||||||||||||||||||||||||||||||
purchases of property, plant and equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
non-cash financial activity: | |||||||||||||||||||||||||||||||||||||||||||||||||
net income | 15,961,000 | 17,368,000 | 10,297,000 | 61,897,000 | 10,018,000 | 4,987,000 | 4,222,000 | 2,006,000 | 917,000 | ||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
non-cash interest expense, net/interest (income) | |||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | |||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 0 | 0 | 66,398,000 | -654,000 | 0 | 34,152,000 | 0 | 0 | 36,396,000 | 0 | 0 | 32,980,000 | 0 | 0 | 40,302,000 | 0 | 0 | 48,544,000 | |||||||||||||||||||||||||||||||
noncash financial activity: | |||||||||||||||||||||||||||||||||||||||||||||||||
accrued income taxes payable | -67,000 | 1,668,000 | |||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by (used in) operating activities | 13,358,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
unrealized loss on marketable securities | |||||||||||||||||||||||||||||||||||||||||||||||||
non-cash interest expense on liability related to sale of future royalties | |||||||||||||||||||||||||||||||||||||||||||||||||
accrued sales deduction | 4,675,000 | 6,322,000 | 1,903,000 | ||||||||||||||||||||||||||||||||||||||||||||||
exercise of warrants | |||||||||||||||||||||||||||||||||||||||||||||||||
non-cash interest expense, net/ interest income | |||||||||||||||||||||||||||||||||||||||||||||||||
non cash interest expense, net/interest income | 155,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in) provided by operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) loss on marketable securities | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred product revenue | 4,389,000 | 6,398,000 | 416,000 | 3,551,000 | |||||||||||||||||||||||||||||||||||||||||||||
cash settlement of debt to equity conversion | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred legal fees included in accrued expenses | |||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income from continuing operations to net cash from (used in) operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on marketable securities | -86,000 | 89,000 | 0 | 1,000 | -2,000 | 8,000 | |||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income from continuing operations to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities | 4,152,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation expense | 704,000 | 652,000 | 667,000 | 491,000 | 432,000 | 337,000 | 130,000 | 53,000 | 52,000 | ||||||||||||||||||||||||||||||||||||||||
interest receivable | -192,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable and accrued expenses | 2,939,000 | 2,998,000 | 1,103,000 | 238,000 | |||||||||||||||||||||||||||||||||||||||||||||
capitalized patent defense costs | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from convertible debt issuance | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
repayment of secured notes payable | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
financing costs and underwriters discounts | -29,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
conversion of convertible notes | 4,211,000 | 258,000 | 10,418,000 | ||||||||||||||||||||||||||||||||||||||||||||||
initial value of interest make-whole derivative issued in connection with the convertible debt | |||||||||||||||||||||||||||||||||||||||||||||||||
initial value of conversion option reported in equity | |||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
initial value of interest make-whole derivative | |||||||||||||||||||||||||||||||||||||||||||||||||
issued in connection with the convertible debt | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
inventory | -873,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile loss to net cash used | |||||||||||||||||||||||||||||||||||||||||||||||||
in operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
unrealized (loss) on marketable securities | |||||||||||||||||||||||||||||||||||||||||||||||||
patent defense costs | |||||||||||||||||||||||||||||||||||||||||||||||||
conversion of preferred stock | |||||||||||||||||||||||||||||||||||||||||||||||||
initial value of conversion reported in equity | |||||||||||||||||||||||||||||||||||||||||||||||||
change in fair value of warrant liability | 294,000 | 144,000 | 328,000 | ||||||||||||||||||||||||||||||||||||||||||||||
income from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
loss from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile loss from continuing operations to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of property and equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
amortization of deferred financing costs | 84,000 | 81,000 | 83,000 | ||||||||||||||||||||||||||||||||||||||||||||||
interest payable | -20,000 | -12,000 | 133,000 | ||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of underwriters discounts | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of (payments on) secured notes payable | |||||||||||||||||||||||||||||||||||||||||||||||||
financing costs | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest-continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest-discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
noncash conversion of preferred stock to common stock | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by operating activities from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of offering costs | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of secured notes payable | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash provided by financing activities from continuing operations | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest—continuing operations | 800,000 | 688,000 | |||||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest—discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
loss from discontinued operations | |||||||||||||||||||||||||||||||||||||||||||||||||
deferred financing costs |